检索各大制药公司进入临床试验药物情况的网站？ The Larvol Group Launches Free Online Pharmaceutical Database of Trials and Products - Larvol Sigma San Francisco, CA – June 26, 2013 - The Larvol Group, LLC announced today that it has officially launched Larvol Sigma, a free pharmaceutical intelligence online resource developed to enable more efficient access to clinicaltrials.gov and EudraCT. With a database containing over 5,000 drugs and more than 150,000 drug trials across all major indications, Larvol Sigma is designed to meet the specific needs of investigators, researchers and industry professionals. "We are excited to share this new product," said company president Bruno Larvol. "We have worked closely with several large pharmaceutical companies to develop a user-friendly pipeline platform with advanced analytics that allows users to focus on specific diseases, companies and mechanisms of action." To view Larvol Sigma, please visit www.larvolsigma.com. The Larvol Group will be hosting a live Webinar to demonstrate the new platform's capabilities on July 30, 2013 at 9am PDT. Please visit for more details. About The Larvol Group, LLC: Founded in 2004, The Larvol Group (www.larvol.com) is a San Francisco-based competitive intelligence company that provides innovative business intelligence services for the pharmaceutical industry. Their customized Market Intelligence Reports track relevant news, clinical trials and developments in the competitive landscape of a given indication. Drawing on the knowledge of over 100 professionals, The Larvol Group has expertise in all major therapeutic areas, including oncology, cardiovascular disease, metabolic diseases, CNS, immunology, women's health and pain management. Their diverse portfolio of clients includes top pharmaceutical companies and small to midsized biotech firms. For more information regarding how The Larvol Group can assist your organization, please contact Natalie Gulley at natalie.gulley@larvol.com or 415.874.3310.查看更多
第1天
关注盖德视界
添加小助手
